Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Verastem reported $-21309000 in Operating Profit for its fiscal quarter ending in September of 2023.

Operating Profit Change Date
AbbVie USD 2.28B 2.23B Sep/2023
Alaunos Therapeutics USD -8664000 682K Sep/2023
AstraZeneca USD 1.95B 502M Sep/2023
Curis USD -12368000 230K Sep/2023
Cytokinetics USD -122265000 216K Sep/2023
Gilead Sciences USD 2.62B 958M Sep/2023
Incyte USD 214.7M 20.92M Sep/2023
Laboratory Of America USD 252.3M 14M Sep/2023
Pfizer USD -2927000000 5.1B Sep/2023
Roche Holding CHF 9.76B 3.84B Jun/2023
TG Therapeutics USD 114.78M 159.46M Sep/2023
Verastem USD -21309000 1.02M Sep/2023